Test Price
1,800 AEDโ Home Collection Available
Disopyramide Drug Level Monitoring Test in UAE | 1800 AED | DHA Licensed Laboratory
Executive Summary & Core Metrics
- Diagnostic Accuracy: 99.9% sensitivity via ISO-accredited immunoassay processing with internal quality controls.
- Premium Home Collection: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Complimentary telephonic post-test interpretation by a DHA-licensed General Practitioner.
- Insurance Verification: Direct billing confirmation via WhatsApp +971 54 548 8731.
- DHA Licensed Facility: Premises 105, Floor 1, Building 33, Dubai Healthcare City โ License No. 1143.
Test Overview & Methodology
The Disopyramide Drug Level test quantifies the serum concentration of disopyramide (Norpace) to maintain therapeutic efficacy while minimising cardiotoxicity risk in patients managed for cardiac arrhythmias. A specialised immunoassay with embedded quality controls measures the drug concentration, enabling cardiologists to tailor dosing with precision. Serum must be collected in a plain red-top tube and separated from cells immediately to prevent analyte degradation before refrigerated transport to the processing laboratory.
| Feature | DNA Labs UAE Service | Closest Alternative |
|---|---|---|
| Methodology | Specialised Immunoassay with internal quality controls and batch standardisation | Standard Immunoassay โ batch protocols may vary |
| Turnaround Time | 2โ3 weeks after sample receipt by the 7th of the month (specialised batch processing) | Unspecified; often exceeds 4 weeks |
| Home Collection | VIP Mobile Phlebotomy & Cold-Chain Courier (8โฏAMโ11โฏPM, daily) | Not available or location-restricted |
| Post-Test Support | Telephonic clinical guidance with DHA-licensed General Practitioner | Basic report delivery only |
| Price | 1,800 AED (all-inclusive) | Varies; often higher without home collection |
Physician Insight & Safety Protocols
Dr. Ajay Singh โ General Practitioner (DHA ID: 36234132)
โInterpreting disopyramide concentrations accurately requires careful correlation with renal function, concurrent medications, and serial ECG changes because the therapeutic window is narrow and toxicity can mimic the very arrhythmia being treated. I advise clinicians never to base dosing decisions on a single isolated level โ always evaluate the trend together with the patientโs clinical trajectory. Our laboratory team provides structured post-test telephonic support to help you act on the results confidently.โ
Medication Advisory
Maintain strict adherence to your prescribed dosing schedule. Do not stop, start, or modify the dosage of disopyramide without explicit instruction from your treating cardiologist. Consistent timing between your last dose and blood draw is essential for accurate trough level measurement. If you miss a dose, never double the next one โ contact your healthcare provider for guidance.
Safety Exclusion Criteria & Emergency Red Flags
- Sample Rejection: Serum collected in SST gel barrier tubes will be rejected. Use only a plain red-top tube; serum must be separated from cells within 30 minutes of collection to prevent drug degradation.
- Mandatory Documentation: A fully completed Test Send Out Consent Form (Form 35) is required before processing โ samples without this form will not be accepted.
- Emergency Signs (seek immediate medical attention): Severe dizziness, syncope, palpitations, blurred vision, difficulty urinating, or acute confusion โ these may indicate disopyramide toxicity requiring urgent evaluation.
Patient FAQ & Clinical Guidance
1. What is the purpose of the Disopyramide drug level test?
This test measures the concentration of disopyramide in your serum to confirm the drug remains within the therapeutic range. Maintaining the correct level helps control heart rhythm disorders while reducing the risk of toxicity or suboptimal treatment response.
2. How should I prepare for the blood sample collection?
No fasting is required. Inform the phlebotomist about all medications you are taking and sign the mandatory Test Send Out Consent Form (Form 35). The specimen must be drawn into a plain red-top tube and handled according to strict pre-analytical protocols to preserve drug stability.
3. When can I expect to receive my results?
Results are typically reported within 2โ3 weeks after the laboratory receives the sample, provided it arrives by the 7th of the month. This timeline accommodates specialised batch processing and rigorous quality control. You will receive a secure digital report accompanied by expert telephonic interpretation.
4. Can I take other medications while on disopyramide?
Many drugs interact with disopyramide and can alter its level or toxicity profile. Always provide an updated medication list to your phlebotomist and treating physician. Never start, stop, or adjust any medication without consulting your cardiologist.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates under the regulatory oversight of the Dubai Health Authority (DHA Facility License No. 1143) and complies fully with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields for all electronic health data handling. Clinical testing safety and patient consent processes adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. Your personal and medical information is encrypted, access-controlled, and never shared without explicit authorisation.
Clinical & Logistical Metadata
| Test Name | Disopyramide Drug Level Monitoring (Serum) |
| Price (AED) | 1,800 AED |
| Turnaround Time | 2โ3 weeks after sample receipt by the 7th of the month |
| Sample Type / Matrix | Serum (peripheral blood) โ plain red-top tube, immediate cell separation required |
| Methodology Used | Specialised Immunoassay with internal quality controls and batch standardisation |
| ICD-10-CM Code | Z51.81 (Encounter for therapeutic drug level monitoring) |
| LOINC Code | 3395-7 (Disopyramide [Mass/volume] in Serum or Plasma) |
| DHA Facility License & Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians